Patient characteristics
| Baseline characteristics . | Total (N = 187) . |
|---|---|
| Median age at transplant, y (range) | 57 (31-71) |
| Sex: male | 122 (64%) |
| Median time from diagnosis to transplant, mo (range) | 3.6 (1-75) |
| Number of organs involved | |
| Cardiac only, n (%) | 32 (17%) |
| Cardiac + 1 other organ, n (%) | 105 (56%) |
| Cardiac + ≥ 2 other organs, n (%) | 50 (27%) |
| Baseline cardiac measurements, median (range) | |
| Septal thickness, mm (n = 185) | 14 (9-25) |
| Posterior wall thickness, mm (n = 159) | 14 (9-26) |
| Ejection fraction, % (n = 187) | 63 (28-84) |
| Cardiac output, l/min (n = 164) | 5.8 (2.7-12.8) |
| LV mass index, g/m2 (n = 181) | 124 (60-270) |
| Troponin, ng/ml (n = 169) | 0.02 (< 0.01-0.9) |
| NT-Pro BNP, pg/ml (n = 100) | 2686 (22-35 000) |
| BNP, pg/ml (n = 116) | 330 (18-3050) |
| Other laboratory characteristics, median (range) | |
| Serum creatinine, mg/dl | 1.1 (0.7-12) |
| Serum albumin, gm/dl | 2.9 (0.8-4.4) |
| Bone marrow plasma cell, % | 7% (1-78) |
| Baseline characteristics . | Total (N = 187) . |
|---|---|
| Median age at transplant, y (range) | 57 (31-71) |
| Sex: male | 122 (64%) |
| Median time from diagnosis to transplant, mo (range) | 3.6 (1-75) |
| Number of organs involved | |
| Cardiac only, n (%) | 32 (17%) |
| Cardiac + 1 other organ, n (%) | 105 (56%) |
| Cardiac + ≥ 2 other organs, n (%) | 50 (27%) |
| Baseline cardiac measurements, median (range) | |
| Septal thickness, mm (n = 185) | 14 (9-25) |
| Posterior wall thickness, mm (n = 159) | 14 (9-26) |
| Ejection fraction, % (n = 187) | 63 (28-84) |
| Cardiac output, l/min (n = 164) | 5.8 (2.7-12.8) |
| LV mass index, g/m2 (n = 181) | 124 (60-270) |
| Troponin, ng/ml (n = 169) | 0.02 (< 0.01-0.9) |
| NT-Pro BNP, pg/ml (n = 100) | 2686 (22-35 000) |
| BNP, pg/ml (n = 116) | 330 (18-3050) |
| Other laboratory characteristics, median (range) | |
| Serum creatinine, mg/dl | 1.1 (0.7-12) |
| Serum albumin, gm/dl | 2.9 (0.8-4.4) |
| Bone marrow plasma cell, % | 7% (1-78) |
LV indicates left ventricle; NT-Pro, N-terminal-pro; and BNP, brain natriuetic peptide.